Creative Planning - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2019$35,000
-22.2%
10,800
-48.1%
0.00%
Q3 2019$45,000
-44.4%
20,800
-19.4%
0.00%
Q2 2019$81,000
-19.0%
25,800
-4.1%
0.00%
Q1 2019$100,000
+37.0%
26,900
+7.1%
0.00%
Q4 2018$73,000
+10.6%
25,1190.0%0.00%
Q3 2018$66,000
+17.9%
25,119
+4.7%
0.00%
Q2 2018$56,000
-21.1%
24,0000.0%0.00%
Q1 2018$71,000
-23.7%
24,000
-29.4%
0.00%
Q4 2017$93,000
-29.0%
34,000
-12.1%
0.00%
-100.0%
Q3 2017$131,000
+47.2%
38,670
+7.4%
0.00%
Q2 2017$89,000
-20.5%
36,000
-27.1%
0.00%
-100.0%
Q1 2017$112,000
-14.5%
49,350
-20.1%
0.00%0.0%
Q4 2016$131,000
-41.0%
61,760
-6.8%
0.00%0.0%
Q3 2016$222,000
+64.4%
66,260
+54.6%
0.00%0.0%
Q2 2016$135,000
+12.5%
42,850
+18.7%
0.00%0.0%
Q1 2016$120,000
-33.0%
36,100
-28.8%
0.00%0.0%
Q4 2015$179,000
+65.7%
50,697
+137.1%
0.00%0.0%
Q3 2015$108,000
+17.4%
21,383
+49.5%
0.00%0.0%
Q2 2015$92,000
-8.9%
14,300
-3.4%
0.00%0.0%
Q1 2015$101,000
-15.1%
14,800
-9.5%
0.00%0.0%
Q4 2014$119,000
+0.8%
16,357
+1.0%
0.00%0.0%
Q3 2014$118,000
-22.4%
16,195
+0.8%
0.00%
-50.0%
Q2 2014$152,000
+10.1%
16,061
-3.2%
0.00%0.0%
Q1 2014$138,000
+72.5%
16,596
+75.1%
0.00%
+100.0%
Q4 2013$80,000
+50.9%
9,476
+41.9%
0.00%0.0%
Q3 2013$53,000
+76.7%
6,678
+71.7%
0.00%0.0%
Q2 2013$30,0003,8900.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,465,000$3,853,0001.56%
SMH CAPITAL ADVISORS INC 93,708$246,0000.42%
West Family Investments, Inc. 627,800$1,651,0000.39%
KENNEDY CAPITAL MANAGEMENT LLC 7,082,858$18,628,0000.35%
ARMISTICE CAPITAL, LLC 1,800,000$4,734,0000.28%
BRANDES INVESTMENT PARTNERS, LP 3,936,719$10,354,0000.23%
ROCKY MOUNTAIN ADVISERS, LLC 14,300$38,0000.13%
Zebra Capital Management LLC 74,695$196,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 5,968,105$15,696,0000.09%
CREDIT AGRICOLE S A 471,644$1,240,0000.06%
View complete list of PDL BIOPHARMA INC shareholders